Who Paid My Doc
Gregory Esper
Clinical Neurophysiology Atlanta, GA Medical Doctor
NPI 1790792166 CMS profile 471541
1365 Clifton Rd Ne, Clinic A, 3Rd Floor, Atlanta, GA 30322
General payments
$2,852
Research payments
$0
Ownership & investment interest
$0
Through program year 2021, Gregory Esper of Atlanta, GA is reported in the CMS Open Payments database as having received $2,852 across 4 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 62nd percentile of Clinical Neurophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $2,813 | 2 | |
| 2020 | General | $19 | 1 | |
| 2019 | General | $20 | 1 |
Beside peers
- Gregory Esper
- Clinical Neurophysiology median
- Middle half of Clinical Neurophysiology
- National median
In program year 2025, general payments to Gregory Esper were reported at $0. Among 259 Clinical Neurophysiology profiles paid that year, the median was $435 and the middle half received between $121 and $1,917.
Show as a table
| Year | Gregory Esper | Clinical Neurophysiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $20 | $306 | $88–$1,636 | $163 |
| 2020 | $19 | $299 | $85–$1,847 | $114 |
| 2021 | $2,813 | $325 | $96–$2,308 | $132 |
| 2022 | $0 | $395 | $106–$1,957 | $149 |
| 2023 | $0 | $388 | $120–$1,718 | $160 |
| 2024 | $0 | $471 | $137–$1,931 | $164 |
| 2025 | $0 | $435 | $121–$1,917 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 27 drugsPart D claims
818
Drug cost
$358,315
Branded share of claims
12.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | Brand | 13 | $311,398 | |
| Aimovig Autoinjector Erenumab-Aooe | Brand | 29 | $26,758 | |
| Gabapentin | Generic | 193 | $4,858 | |
| Lacosamide | Generic | 14 | $2,508 | |
| Fentanyl | Generic | 12 | $2,056 | |
| Propranolol Hcl Er Propranolol Hcl | Brand | 23 | $1,370 | |
| Levetiracetam | Generic | 42 | $1,352 | |
| Duloxetine Hcl | Generic | 85 | $1,236 | |
| Galantamine Hbr | Generic | 11 | $1,093 | |
| Topiramate | Generic | 27 | $837 |
The 10 drugs with the highest cost, of 27 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 9 billing codesPaid by Medicare
$13,013
Medicare patients
81
Services billed
127
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 69% | |
| Arthritis | 57% | |
| Depression | 33% | |
| Ischemic heart disease | 28% | |
| Chronic kidney disease | 25% | |
| Diabetes | 22% | |
| Osteoporosis | 20% | |
| Heart failure | 17% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
4 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Neurophysiology in Georgia
Michael Rivner
Clinical Neurophysiology · Macon, GA
Kashyap Patel
Clinical Neurophysiology · Statesboro, GA
Ashish Kabir
Clinical Neurophysiology · Dalton, GA
Joseph Hormes
Clinical Neurophysiology · Marietta, GA
Sachin Kedar
Clinical Neurophysiology · Atlanta, GA
William Roche
Clinical Neurophysiology · Macon, GA
Related records
Clinical Neurophysiology in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Neurophysiology
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.